Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsConaghan discussed the potential of LEVI-04 for knee osteoarthritis at ACR 2025.
The adaptive PRImus-AD phase 2a trial will evaluate the safety and efficacy of PRI-002, a novel investigational agent, in patients with mild cognitive impairment or mild Alzheimer disease.
Treatment with etalanetug reduced cerebrospinal fluid eMTBR-tau243 by 62% and plasma eMTBR-tau243 by 78% at 3 months in patients with dominantly inherited Alzheimer disease.
A recent study reveals that Araclon's ABvac40 vaccine may slow cortical perfusion decline in patients with Alzheimer disease, suggesting potential cognitive benefits.
In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.
Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT
Deep Capillary Plexus Microaneurysms A Sign of CKD in Diabetic Retinopathy
1.
Research discovery halts childhood brain tumor before it forms
2.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
3.
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma
4.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
5.
a cutting-edge cancer diagnostic tool.
1.
Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care
2.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
3.
Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management
4.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
5.
Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge